Peer Reviewed Publication Library

Advancing Medical Knowledge: Explore Our Peer Reviewed Clinical Studies


Jan 2024
Acellular human amniotic fluid-derived extracellular vesicles as a novel anti-inflammatory therapeutic against SARS-COV-2 Infection
May 2023
Extracellular Vesicles: A promising therapy against SARS-CoV-2 infection
Molecular Therapy
November 2022
Human amniotic fluid derived extracellular vesicles attenuate T Cell immune response
Frontiers in Immunology
December 2021
Proof-of-concept trial of an amniotic fluid-derived extracellular vesicle biologic for treating high risk patients with mild-to-moderate acute COVID-19 infection, Biomaterials and Biosystems
Biomaterials and Biosystems
December 2021
Amniotic fluid-derived extracellular vesicles: characterization and therapeutic efficacy in an experimental model of bronchopulmonary dysplasia, Cytotherapy
March 2021
Case Report: Administration of Amniotic Fluid-Derived Nanoparticles in Three Severely Ill COVID-19 Patients
Frontiers in Medicine
Treatment of a COVID-19 long hauler with an amniotic fluid-derived extracellular vesicle biologics
Respiratory Medicine Case Reports